Skip to Content

M 228 (Pioglitazone Hydrochloride 30 mg (base))

Pill with imprint M 228 is White, Round and has been identified as Pioglitazone Hydrochloride 30 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 228

Pioglitazone hydrochloride 30 mg (base) M 228
Pioglitazone hydrochloride 30 mg (base) M 228  Front
Pioglitazone hydrochloride 30 mg (base) M 228  Back
Pioglitazone hydrochloride 30 mg (base) M 228

Pioglitazone Hydrochloride

Imprint
M 228
Strength
30 mg (base)
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Thiazolidinediones
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
hydroxypropyl cellulose (type h), lactose monohydrate, magnesium stearate, sodium lauryl sulfate, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-0228 Mylan Pharmaceuticals Inc.
51079-0514 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M 228"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.